Context This overview presents the updated European Association of Urology (EAU)
guidelines for muscle-invasive and metastatic bladder cancer (MMIBC). Objective To …

Context We present an overview of the updated 2023 European Association of Urology
(EAU) guidelines for muscle-invasive and metastatic bladder cancer (MMIBC). Objective To …

Context Invasive bladder cancer is a frequently occurring disease with a high mortality rate
despite optimal treatment. The European Association of Urology (EAU) Muscle-invasive and …

Background. Platinum-based neoadjuvant chemotherapy has been shown to improve
survival outcomes in muscle-invasive bladder cancer patients. We performed a systematic …

Background Tri-modality therapy (TMT) is a recognized treatment strategy for selected
patients with muscle-invasive bladder cancer (MIBC). Objective Report long-term outcomes …

Abstract Context The European Association of Urology (EAU) guidelines panel on Muscle-
invasive and Metastatic bladder cancer (BCa) updates its guidelines yearly. This updated …

This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)
for Bladder Cancer focuses on systemic therapy for muscle-invasive urothelial bladder …

OBJECTIVES:: To update a systematic review and meta-analysis that assesses the effect of
neoadjuvant chemotherapy in the treatment of patients with invasive bladder cancer …

Bladder cancer is the fourth most common cancer in the United States. Urothelial carcinoma
that originates from the urinary bladder is the most common subtype. These NCCN Clinical …

CONTEXT: New data regarding treatment of muscle-invasive and metastatic bladder cancer
(MiM-BC) has emerged and led to an update of the European Association of Urology (EAU) …